在T2喘中,雄激素通过在支气管上皮细胞中介于METTL3而具有治疗潜力
Zhifeng Chen1, Yulin Shang2, Wentao Duan3
1Department of Respiratory and Critical Care Medicine, The Second Xiangya Hospital, Central South University, 139 Middle Renmin Road, Changsha, Hunan 410011, China.
International immunopharmacology
|October 6, 2024
概括
二 (DHT) 可能通过促进支气管细胞中的METTL3来治疗2型喘. 这项研究发现,DHT可以减少喘的严重程度和炎症,为过敏性喘提供新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 2型 (T2) 喘与雄激素水平有关;雄激素可以缓解症状.
- 参与m6A修饰的METTL3通过抑制Th2细胞分化来抑制T2喘的发展.
- 像二测试 (DHT) 这样的雄激素在T2喘中通过METTL3的特定作用是未知的.
研究的目的:
- 通过METTL3.3调查DHT对T2喘进展的影响.
- 在患者和小鼠模型中探索DHT,METTL3和T2喘严重程度之间的关系.
主要方法:
- 对T2喘患者的激素和METTL3mRNA水平进行临床分析.
- 在T2喘小鼠模型中给予DHT和17β-雌二醇 (E2).
- 使用小鼠支气管上皮细胞 (BECs) 进行体外研究,以检查依赖METTL3的机制.
主要成果:
- T2喘患者的DHT和METTL3mRNA水平较低,E2水平较高,与喘严重程度相关.
- 在小鼠中,DHT治疗改善了肺功能,减少了呼吸道炎症,并抑制了Th2细胞分化,同时恢复了METTL3水平.
- 在体外,DHT促进了BEC中的METTL3表达,抑制了T2炎症反应.
结论:
- DHT通过增强支气管上皮细胞中的METTL3表达来证明T2喘的治疗潜力.
- DHT的机制涉及抑制Th2细胞分化,这表明了过敏性喘的新型治疗策略.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
241
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
241
01:20Asthma: Pathogenesis and Management
363
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
363
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
235
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
235
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:24Antiasthma Drugs: Methylxanthines
203
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
203
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
254
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
254